Afatinib in advanced non-small-cell lung cancer

Author： Di Maio Massimo Gridelli Cesare Grossi Francesco Novello Silvia de Marinis Filippo

ISSN： 1758-1966

Source： Lung Cancer Management, Vol.2, Iss.6, 2013-12, pp. : 493-504

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clinical observation of pemetrexed on advanced non-small-cell lung cancer

By Zheng Yongfa Ge Wei Zhang Ling Zhao Zhenyu Jie Fangfang

The Chinese-German Journal of Clinical Oncology, Vol. 10, Iss. 3, 2011-03 ,pp. : 140-143

Springer Publishing Company

Access to resources Recommend Favorite

Erlotinib and Gefitinib for Elderly Patients with Advanced Non-small-cell Lung Cancer

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 5, 2014-06 ,pp. : 646-650

Bentham Science Publishers

Access to resources Recommend Favorite

Conference Scene: Australia Lung Cancer Conference 2012: focus on systemic treatment of advanced non-small-cell lung cancer

By Vincent Mark

Lung Cancer Management, Vol. 2, Iss. 1, 2013-02 ,pp. : 27-30

Future Medicine

Access to resources Recommend Favorite

Rare mutations in non-small-cell lung cancer

By D’Arcangelo Manolo D’Incecco Armida Cappuzzo Federico

Future Oncology, Vol. 9, Iss. 5, 2013-05 ,pp. : 699-711

Future Medicine

Access to resources Recommend Favorite

Evolution of modern-era radiotherapy strategies for unresectable advanced non-small-cell lung cancer

By Selek Ugur Chang Joe Y

Lung Cancer Management, Vol. 2, Iss. 3, 2013-06 ,pp. : 213-225

Future Medicine

Access to resources Recommend Favorite